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advertisement of pharmaceutical 
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eration Council (GCC), comparing 
them to those of the UK and US. The 
findings suggest that Kuwaiti and GCC 
cultural communication styles result 
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to promote health and health literacy, 
with an emphasis on fatalistic attitudes 
found in the cultural environment of 
Arab Gulf states.
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Introduction
For safety purposes, communication related to the promotion of pharmaceuticals and 
foods is regulated globally. Individuals seeking medications have an ailment from which 
they desire relief, which makes them particularly vulnerable. To protect them, the laws of 
many countries place ‘specific restrictions’ on the promotion and sales of pharmaceutical 
products because medication should not be treated as ‘an ordinary general commodity’.1 
While the vulnerability of some patients must be considered in the advertising of medica-
tions, it is also important for regulatory bodies to promote healthy living and ensure that 
individuals have the ability to self-medicate.2
There is no internationally recognised standard for regulating the promotion of health-re-
lated products such as pharmaceuticals. This paper contributes to the existing knowledge 
on pharmaceutical promotion in Kuwait in several ways. First, it explains the effects of 
different policies for the promotion of pharmaceuticals in the UK and the US. Second, 
it highlights the importance of examining healthcare promotion in Kuwait and the 
Gulf Cooperation Council (GCC). Third, it offers an analysis of existing laws related to 
healthcare promotion from the GCC Health Ministers’ Council, Kuwait’s Parliament and 
Kuwait’s Ministry of Health. Finally, it concludes on the underlying differences between 
the policies for the promotion of pharmaceuticals in Kuwait and the Gulf as compared to 
the UK and the US.
Kuwaiti regulations were compared to those of the US and the UK because the amount 
of knowledge on health literacy and its promotion in those two countries far outweighs 
the knowledge generated on the same topic in developing nations.3 Research examining 
health literacy and promotion clearly points to the importance of culture and social con-
text.4 However, some studies conducted in the US and the UK examine how particular 
subgroups – such as Arabs and Muslims – with sociocultural similarities to individuals 
in the Arab Gulf states receive information with regard to physical5 and psychological6 
health. Furthermore, the UK, the US and the GCC states are considered nations with high 
gross national incomes. Gross national income is a better predictor of measurements of 
1  Medicines and Healthcare Products Regulatory Agency (MRHA), ‘The Blue Guide: Advertising and 
Promotion of Medicines in the UK’, p. 9. Available at https://www.gov.uk/government/publications/
blue-guide-advertising-and-promoting-medicines (accessed 25 August 2016).
2  Ibid., p. 25.
3  Andrew Pleasant, ‘Health Literacy Around the World: Part 1. Health Literacy Efforts Outside of the 
United States’, in Lyla M. Hernandez et al., Health Literacy (Washington, DC: National Academies Press 
[US], 2013), pp. 97–206. Available at https://www.ncbi.nlm.nih.gov/books/NBK202438/pdf/Bookshelf_
NBK202438.pdf#page=114 (accessed 2 July 2017).
4  Mayagah Kanj and Wayne Mitic, ‘Promoting Health and Development: Closing the Implementa-
tion Gap’, unpublished conference document, 7th Global Conference on Health Promotion, Nairobi, 
October 2009.
5  Aasim I. Padela and Afrah Raza, ‘American Muslim Health Disparities: The State of the Medline Litera-
ture’, Journal of Health Disparities Research and Practice 8/1 (2015), article 1.
6  Sobia Ali-Faisal, ‘What’s Sex Got to Do With It? The Role of Sexual Experience in the Sexual Attitudes, 
and Sexual Guilt and Anxiety, of Young Muslim Adults in Canada and the United States’, Journal of 
Muslim Mental Health 10/2 (2016), pp. 27–41. DOI: 10.3998/jmmh.10381607.0010.202.
6 Regulation of Healthcare Advertisements
societal health, such as maternal and infant mortality, than other sociocultural factors, 
such as whether a nation is inhabited by a majority of Muslims or otherwise.7 For these 
reasons, the US and the UK provide a useful reference point for comparison.
Different Approaches to Regulating Health Promotion
European and British laws regulate medications, medical devices and herbal and/or 
homeopathic products to ensure they are not endangering consumer safety.8 In the UK, 
organisations such as the Medicines and Health Products Regulatory Agency (MHRA) 
regulate the sales of such products by licensing medications on the basis of safety accord-
ing to a prepared Summary of Product Characteristics (SPC). Legislation demonstrates a 
commitment to consumer protection when advertising medications to healthcare profes-
sionals for the purposes of enabling consumers’ self-medication.9
Although advertising prescription medications to consumers is prohibited in Europe and 
the UK,10 over-the-counter medications advertisements are regulated by the Propriety 
Association of Great Britain (PAGB) in the UK. Other organisations regulate the promo-
tion of such products, including Ofcom and the Advertising Standards Authority (ASA). 
Ofcom is the UK’s independent regulator of broadcast media. Its statutory role allows it 
to ensure that broadcast media meet a certain professional standard. Ofcom is respon-
sible for ‘sponsorship and product placement’.11 Non-broadcast advertising materials, 
such as billboards and print ads, are then regulated by the ASA. Newer media, such as 
social media, are regulated in ways similar to magazine advertising by the ASA.12 The ASA 
ensures that advertisements are ‘legal, decent, honest and truthful’,13 and helps the adver-
tising industry maintain such a standard through a similar organisation, the Committee of 
Advertising Practice (CAP). Thus, UK regulators consider the medium in which an adver-
tisement appears when deciding on the institution that regulates it, even if regulators try 
to focus solely on content.
Across the Atlantic, the US Food and Drug Administration (FDA) provides different 
requirements for print and broadcast advertisements of prescription drugs directly to con-
sumers.14 Print ads must include a brief description of the drug, risks of the prescription, 
and a call for patients to report negative side effects to the FDA.15 This information for 
7  Junaid Abdul Razzak, Uzma Rahim Khan, Iqbal Azam, Muazzam Nasrullah, Omrana Pasha, M. Malik 
and A. Ghaffar, ‘Health Disparities Between Muslim and Non-Muslim Countries’, Eastern Mediterranean 
Health Journal 17/9 (2011), pp. 654–64, at p. 659.
8  MHRA, ‘Blue Guide: Advertising and Promotion of Medicines in the UK’, p. 9.
9  Ibid., p. 10.
10  Ibid.
11  Ibid., p. 56.
12  Ibid., p. 101.
13  Ibid., p. 56.
14  FDA, ‘Prescription Drug Advertising’. Available at http://www.fda.gov/Drugs/ResourcesForYou/Con-
sumers/PrescriptionDrugAdvertising/ucm072077.htm (accessed 26 July 2016).
15  Ibid.
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FDA-approved usage must be communicated in a way that is consumer-friendly.16 Broad-
cast media, on the other hand, must present the drug’s most important risks in the audio 
component and must – at minimum – provide resources for determining secondary risks.17 
Broadcast media may direct consumers to a company’s website for further information.
The Effects of Health Promotion Policy on Consumers
In the US, physicians often support the regulation of direct-to-consumer (DTC) adver-
tisements. Huh and Langteau18 found that physicians recognise that DTC advertising can 
educate patients about medical conditions and treatment options, although they support 
its regulation. Physicians are concerned that DTC advertising can negatively affect the 
physician–patient relationship by undermining the expertise of the medical professional 
when a patient makes ‘demands for unnecessary or inappropriate drugs’.19
Patients’ demands are welcomed by the pharmaceutical and healthcare industry, whose 
practices have led to many analyses of DTC advertisements and their customers’ percep-
tions. For example, consumers are more likely to respond favourably to advertised drugs 
when the risks are communicated orally, creating differences in the interpretations of the 
ads depending on the media in which they appear.20 Similarly, Huh and Cude found that 
while all prescription drug websites revealed the drugs’ benefits, not all websites provided 
navigational tools to find risks.21
The digital era presents more concerns relating to communicating about prescription 
medications. Approximately 35 percent of patients conduct an online search for treatment 
and prescription medications, which can compromise patient privacy as third-party track-
ing elements are often employed to obtain user information anonymously.22 Further, some 
patients can be susceptible to low-quality information, and physicians’ recommendations 
of websites can be helpful to patients.23 As an example, Kareklas, Muehling and Weber 
confirmed that source credibility affects both the attitude and behavioural intention of 
individuals exposed to promotional messages about vaccinations.24 Therefore, there is a 
16  Wendy Macias, Liza Stavchansky Lewis and Tae Hyun Baek, ‘The Changing Face of Direct-to-Con-
sumer Print Advertising’, Pharmaceutical Medicine 24/3 (2010), pp. 165–77.
17  FDA, ‘Prescription Drug Advertising’.
18  Jisu Huh and Rita Langteau, ‘Presumed Influence of Direct-to-Consumer (DTC) Prescription Drug 
Advertising on Patients: The Physician’s Perspective’, Journal of Advertising 36/3 (2007), pp. 151–72.
19  Ibid., p. 166.
20  Joel J. Davis and Aimee Meader, ‘Beyond Content Analysis: Assessing Fair Balance in DTC Pharma-
ceutical Advertising’, Journal of Medical Marketing: Device, Diagnostic and Pharmaceutical Marketing 9/1 
(2009), pp. 57–66.
21  Jisu Huh and Brenda J. Cude, ‘Is the Information “Fair and Balanced” in Direct-to-Consumer Prescrip-
tion Drug Websites?’, Journal of Health Communication 9/6 (2004), pp. 529–40.
22  Scott Monteith, Tasha Glenn and Michael Bauer, ‘Searching the Internet for Health Information about 
Bipolar Disorder: Some Cautionary Issues’, International Journal of Bipolar Disorders 1/1 (2013), article 
22, p. 3.
23  Ibid., p. 1.
24  Ioannis Kareklas, Darrel D. Muehling and T. J. Weber, ‘Reexamining Health Messages in the Digital 
Age: A Fresh Look at Source Credibility Effects’, Journal of Advertising 44/2 (2015), pp. 88–104.
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need for discerning credible sources in digital media to protect consumer safety when it 
comes to healthcare products.
While some of these concerns are global, there is an ‘urgent need for moving cross-cultural 
advertising research forward’.25 Kuwait provides a robust case study because the country 
imports many pharmaceutical products, which are then registered with the Kuwait Drug 
and Food Control Administration (a division of the Ministry of Health).26 Kuwait also 
spends the most per capita on the pharmaceutical industry in the region. Healthcare 
policy experts expect that number to rise with the incidence of chronic diseases.27 Fortu-
nately, Kuwait has a strongly regulated healthcare promotion policy28 and is a member of 
the GCC committee to harmonise product registration regionally in the pharmaceutical 
industry.29 Like the UK, Kuwait and the GCC do not allow for advertising prescription 
drugs to consumers, unlike the US. Kuwait is also home to a ‘techno-savvy culture’30 and 
has the greatest media freedom of all the GCC states.31
The Case for Studying Kuwaiti Regulation of the 
Promotion of Pharmaceuticals
Although Kuwait already spends a great deal of resources to provide pharmaceuticals 
and healthcare services to its citizens and expatriates,32 an increase in expenditure due 
to rising rates of chronic illnesses is expected.33 Several cultural and lifestyle factors have 
been examined for their impact on the state of public health in Kuwait, and a national 
programme to improve public health explicitly states the need for media regulation that 
supports the national health policies.34 While the regulation of mass media in Kuwait has 
been analysed with regard to media law,35 media ownership models36 and public opinion 
25  Hye-Jin Paek, Jay Yu and Beom Jun Bae, ‘Is On-Line Health Promotion Culture-Bound? Cultural 
Characteristics Manifested in US and South Korean Antismoking Web Sites’, Journal of Advertising 38/1 
(2009), pp. 35–48, at p. 42.
26  Dalia A. Badawi, Yousif Alkhamis, Mohammad Qaddoumi and Kazem Behbehani, ‘National Transpar-
ency Assessment of Kuwait’s Pharmaceutical Sector’, Health Policy 119/9 (2015), pp. 1275–83, at p. 1276.
27  Ibid.
28  Ibid.
29  Ibid., p. 1278.
30  Eisa Al Nashmi, Johanna Cleary, Juan-Carlos Molleda and Melinda McAdams, ‘Internet Political Dis-
cussions in the Arab World: A Look at Online Forums from Kuwait, Saudi Arabia, Egypt and Jordan’, 
International Communication Gazette 72/8 (2010), pp. 719–38, at p. 723.
31  Matt J. Duffy, ‘Arab Media Regulations: Identifying Restraints on Freedom of the Press in the Laws of 
Six Arabian Peninsula Countries’, Berkeley Journal of Middle Eastern & Islamic Law 6/1 (2014), article 2, 
p. 1.
32  Badawi et al., ‘National Transparency Assessment’.
33  Kazem Behbehani, ‘Kuwait National Programme for Healthy Living: First 5-Year Plan (2013–2017)’, 
Medical Principles and Practice 23/1 (2014), pp. 32–42.
34  Ibid.
35  Duffy, ‘Arab Media Regulations’, p. 1.
36  Kjetil Selvik, ‘Elite Rivalry in a Semi-Democracy: The Kuwaiti Press Scene’, Middle Eastern Studies 47/3 
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regarding elections,37 religious issues38 and tribalism,39 there is a gap in the literature that 
examines media regulation in the context of healthcare communication. 
In addition to the direct impact on healthcare policy in Kuwait, examining media regula-
tion in the context of health communication contributes to an improved understanding of 
Kuwaiti media and public health. Although Amin claims that Arab scholars have long ‘been 
encouraged to conduct media research that promotes the politically established goals of 
national development and national unity’,40 a lack of such research in healthcare commu-
nication literature persists. Amin states that Arab researchers would be discouraged from 
voicing criticism relating to the ‘principles, struggle, values, and national traditions of Arab 
society’,41 yet criticisms of religious attitudes,42 cultural customs, nepotism43 and other 
traditions related to the Kuwaiti lifestyle have been published by Kuwaiti health policy 
researchers. Moreover, criticisms of media practices are not uncommon in academic liter-
ature; an example is Onyebadi and Alajmi’s documentation of gift solicitation behaviour 
among journalists in a nation with one of the highest per capita incomes in the world.44
While there is a distance between media practices and media regulation, the tolerance for 
criticism of media regulation in the context of Kuwait could be explained by the coun-
try’s unique national character, which Herb describes as a type of political participation 
in which power is negotiated with members of the political elite.45 Tétrault argues that 
this power-sharing strategy can be partially attributed to Kuwait’s size, because rulers of 
small states are more exposed to the different demands of citizens and cannot suppress 
cultural pluralism as larger Middle Eastern states have done to develop a sense of unity.46 
Elements of this national character are ‘embedded in the reality of legal and economic 
(2011), pp. 477–96.
37  Anastasia Kononova and Mohammad Akbar, ‘Interpersonal Communication, Media Exposure, 
Opinion Leadership, and Perceived Credibility of News and Advertising During December 2012 Parlia-
mentary Election in Kuwait’, International Journal of Communication 9 (2015), pp. 1206–28.
38  Ali A. J. Al-Kandari, ‘Predicting the Clash of Civilizations: The Use and Impact of Religious Media in 
Kuwait’, Journal of Media and Religion 10/4 (2011), pp. 206–23.
39  Ali A. Dashti, Ali A. Al-Kandari and Hamed H. Al-Abdullah, ‘The Influence of Sectarian and Tribal 
Discourse in Newspapers Readers’ Online Comments About Freedom of Expression, Censorship and 
National Unity in Kuwait’, Telematics and Informatics 32/2 (2015), pp. 245–53.
40  Hussein Amin, ‘Freedom As a Value in Arab Media: Perceptions and Attitudes Among Journalists’, 
Political Communication 19/2 (2002), pp. 125–35, at p. 129.
41  Ibid.
42  Behbehani, ‘Kuwait National Programme for Healthy Living’.
43  Nasra M. Shah, Makhdoom A. Shah and Behbehani Jaafar, ‘Predictors of Non-Urgent Utilization of 
Hospital Emergency Services in Kuwait’, Social Science & Medicine 42/9 (1996), pp. 1313–23.
44 Uche Onyebadi and Fawaz Alajmi, ‘Gift Solicitation and Acceptance in Journalism Prac-
tice: An Assessment of Kuwaiti Journalists’ Perspective’, Journalism 17/3 (2014), pp. 348–65. DOI: 
10/1177/1464884914557924.
45  Michael Herb, ‘The Origins of Kuwait’s National Assembly’, LSE Kuwait Programme Paper Series 39 
(London, 2016).
46  Mary Ann Tétreault, Stories of Democracy: Politics and Society in Contemporary Kuwait (New York: 
Columbia University Press, 2000), p. 16.
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dominance’47 by which citizens are favoured through policies such as those requiring the 
private sector to hire Kuwaitis. Al-Sumait notes that the political liberalisations that began 
with the establishment of Kuwait’s first political consultative council in the 1930s and the 
first constitution among the Arab Gulf states in the 1960s have developed ‘with little vio-
lence or continuous external pressures to democratize’.48 Several scholars recognise this 
national character as a factor contributing to Kuwait’s position as the most democratised 
Arab Gulf state.49 Although Ottaway explains that other Arab Gulf states point to the par-
liamentary procedures of Kuwait as an example of democracy’s inefficiency,50 the Kuwaiti 
national character is encouraging because Kuwaitis can use criticisms of media regulation 
that relate to healthcare to create positive change and improve their quality of life.
Improved communication between government officials and healthcare professionals is 
called for in Al-Rubaie, Salek and Walker’s analysis of efficiency in the GCC pharmaceutical 
industry to maximise benefits from medical treatment.51 Currently, health communication 
examinations are welcomed given the rise of regional universities since the early 2000s.52 
While some scholarship has explored cultural obstacles that face the region’s commu-
nication industry53 and the research agendas of scholars,54 fewer education and research 
programmes focus on communication as it applies to health promotion regionally. 
The purpose of this paper is to explore regulation as it applies to advertising and promo-
tion of the healthcare industry in Kuwait and the GCC, taking into consideration the type 
of medium, type of medication and type of audience. It then compares how regulations in 
Kuwait differ from thoses agreed upon by the GCC Health Ministers’ Council.
47  Anh Nga Longva, Walls Built On Sand: Migration, Exclusion, and Society in Kuwait (Boulder, CO: Perseus, 
1997), pp. 144–5.
48  Fahed Al-Sumait, ‘Communicating Politics in Kuwait’, in Philip M. Howard and Muzammil M. Hussain 
(eds), State Power 2.0: Authoritarian Entrenchment and Political Engagement Worldwide (London: Rout-
ledge, 2014), p. 101.
49  Herb, ‘Origins of Kuwait’s National Assembly’; Tétreault, Stories of Democracy; Longva, Walls Built On 
Sand; Al-Sumait, ‘Communicating Politics in Kuwait’.
50  Marina Ottaway, ‘Bahrain: Between the US and Saudi Arabia’, Carnegie Endowment for International 
Peace (Washington, DC, 2011).
51  Mohamed H. Al-Rubaie, Sam Salek and Stuart Walker, ‘An Evaluation of the Efficiency of the Gulf 
Cooperation Council’s Centralized Procedure by the Gulf Regulatory Authorities and Pharmaceutical 
Companies: Recommendations for an Improved Model’, Therapeutic Innovation & Regulatory Science 49/4 
(2015), pp. 560–8.
52  Megan Knight and Caroline Hawtin, ‘The New Global J-School: Issues Arising from the International-
ization and Monetization of Journalism Education’, Journalism & Mass Communication Educator 65/3–4 
(2010), pp. 250–64.
53  Badreya Al-Jenaibi, ‘Disparities Between UAE and Other Public Relations Professionals: Challenges, 
Opportunities, and Cultural Obstacles’, Review of Journalism and Mass Communication 2/2 (2014), pp. 
19–40.
54  Awadh K. Al-Enezi, ‘Why Academics Fail to Utilize Academic-Funded Research Opportunities? An 
Empirical Study’, International Journal of Management 24/4 (2007), pp. 712–26, at p. 712.
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Method
Data was collected using primary qualitative research techniques. In-depth textual analy-
sis was selected to examine regulation regarding the promotion of pharmaceuticals in the 
mass media of Kuwait and the GCC. Consultations with librarians at the British Library in 
London and at the Library of Congress in the US capital, with Kuwaiti lawyers and with 
members of the Office of the Secretariat General of the GCC concluded with a decision 
involving the inclusion of three primary documents in this analysis. 
The first document is Law 38 of 2002, which was published in the official gazette of the 
Kuwaiti government, AlKuwait Alyoum, on 5 May 2002. According to Article 79 of the 
Kuwaiti Constitution,55 the necessary conditions for a law to be published in AlKuwait 
Alyoum include receiving sufficient votes in Parliament and securing the authorisation of 
the Emir. Kuwaiti laws typically call upon ministers to create bylaws to decide how the 
law should be implemented. Since it is the official implementation of Law 38 of 2002, 
the second document is Decree 437 of 2002, decided upon by the Minister of Health and 
published in AlKuwait Alyoum on 27 October 2002. 
The third document, ‘Gulf Code of Pharmaceutical Promotional Practices in the GCC’, was 
compiled by the Gulf Central Drug Registration Committee as a part of an initiative called 
for by the GCC Health Ministers’ Council.56 Regulations developed by the GCC committees 
are not compulsory for member states; rather, they are seen as recommendations.
These documents were collected and analysed in Arabic, a task which was facilitated 
by the qualitative data management software AtlasTi. Categorisations and analysis were 
reached through examination of the literature review of US and British laws, and other 
emergent categories were created as patterns appeared.
Results
Kuwait
Medium Used
First, the two Kuwaiti regulations were examined for specific considerations with regard 
to the medium in which promotional material appears. Law 38 of 2002 includes an article57 
which states that products must be licensed by the Ministry of Health to be advertised in 
the mass media in a way that allows the advertisement to be read, seen, heard or dissem-
inated in any other type of media. Another article of the law delegates the regulation of 
promotional material related to healthcare to the Minister of Health.58
Article 8 of the bylaws contains eight separate clauses that set the criteria for the advertise-
ment of licensed pharmaceuticals. The first clause states that obtaining a licence from the 
relevant authorities within the Ministry of Health is a necessary condition for advertisement. 
55 ‘Article 79’, Kuwaiti Constitution. Available at http://www.kuwaitconstitution.org/kuwaitconstitu-
tionenglish.html (accessed 16 October 2017).
56  Tawfik Khoja (ed.), Gulf Code of Pharmaceutical Promotional Practices in the GCC (Riyadh, 2011).
57  Law 38 of 2002, AlKuwait Alyoum.
58  Ibid.
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The second clause of Article 8 states that text advertising the product must be consistent 
with the uses submitted as a part of the licensing process. Further, advertisements must 
not contain claims that are inconsistent with the information contained in the submit-
ted documents through which the product was registered and licensed with the relevant 
authorities within the Ministry of Health. The second clause also stipulates that some 
products require the inclusion of the statement, ‘You should consult a physician before 
us[ing the product].’59 Further details on which products this condition is necessary for 
are not included. 
The third clause states that advertisements must not contain any phrases or images that 
contradict the teachings of Islam or social customs, outrage public decency, or challenge 
public systems that manage morality and order within the country. 
The fourth clause states that advertisements must describe the product they are advertis-
ing with clearly pictured or written evidence that can be understood by the consumers. It 
prohibits the inclusion of terms or phrases that harm similar products (i.e. competitors) 
that are licensed to be advertised. 
The fifth clause states that a product being advertised must not be described as a substi-
tute for any other substance, through either text or images. Similarly, advertisements must 
not describe the product in a way that may confuse it with others. 
The sixth clause states that tools for creating incentive and encouragement in the adver-
tisement must not contradict any of the regulations and legislations set by other governing 
institutions. For example, health advertisements may not encourage the consumption of 
alcohol because other regulations would prohibit that.
The seventh clause states that the person providing the advertising material must obtain 
consent from the appropriate commission prior to execution of the advertisement. Further 
details about when prior consent is required within the process of developing advertise-
ments are not clearly indicated. 
Finally, the eighth clause states that any other standards and regulations related to health 
advertisements must be considered by additional committees.
Article 13 of the bylaws makes Law 38 of 2002 applicable to various types of advertise-
ments through three provisions. First, the law applies to any kind of information that can 
affect the public, regardless of whether it can be seen, heard or read, for the purposes of 
promoting health-related products and services. Second, the law applies to all methods of 
advertising, including those used to promote prohibited health-related items. Finally, the 
law applies to any advertisement that contains images, graphics, signs and symbols that 
relate to health in printed media. 
59  Minister of Health Decree no. 437 of 2002, AlKuwait Alyoum.
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Medication Advertised
Second, the legal codes were examined for references to type of medication. Article 1 of 
Law 38 of 2002 prohibits certain types of medications from being advertised through mass 
media. Prohibited medications include pharmaceuticals for human medicine, veterinary 
medicine, mixtures and compound substances – whether they are composed of plants, 
animals or chemicals. This law also applies to specialised foods that make health claims to 
treat or influence the general shape or appearance of the body, provide energy and vitality, 
cause weight loss or gain, prevent diseases, provide cosmetic effects, or change the com-
position of parts of the body. 
In the bylaws, there are two references to the regulation on advertising that applies to 
different types of medications. These references appear in Articles 1 and 13. Article 1 states 
that the laws apply to pharmaceuticals to be used on humans, animals and plants. It con-
tinues to include herbal and plant-based medications, mixtures or compounds, cosmetics 
with medical properties, health foods and dietary supplements. The article also contains a 
clause that enables it to be applied to any other items, such as medical devices and equip-
ment that are not included in these categories
Moreover, Article 13 explicitly states that regulations must be implemented on products 
mentioned in the first clause which can affect human health physically or psychologically. 
The inclusion of the term ‘psychologically’ implies that regulation of health promotion 
applies in a holistic way that includes various types of health, including mental health.
Intended Audience
Third, the legal codes were examined for references to the intended audiences of the pro-
motional materials. Law 38 of 2002 does not make such references; however, the bylaws 
make several direct and indirect references to the intended audiences. 
The first clause of Article 13 implies that all health-related products or services that can 
impact human health either physically or psychologically are to be regulated if they address 
the public. Similarly, the fourth clause of Article 8 references the likelihood of both ‘the 
public’ and ‘consumers’ misunderstanding unclear and implicit words or phrases that may 
be abused in the content of the advertisement. Clearly, the end-consumer is an intended 
audience for the promotional material of pharmaceuticals. 
In addition, medical staff are another intended audience for the advertisements according 
to the bylaws. The third clause of Article 6 gives the Ministry of Health the authority to 
examine the medical language contained in advertisements. Medical language must be 
explicit and consistent with the licensed use of the medications. The clause is concerned 
with the impact of these advertisements on public health. In fact, the clause authorises a 
relevant committee within the Ministry of Health to revise text it considers either ambig-
uous or as having the potential for misinterpretation, in order to ensure that its medical 
effects are less damaging. 
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Furthermore, communication practitioners, such as employees of advertising agencies, are 
another intended audience of the law. For example, Article 7 states that the owner of the 
advertisement must provide documentation required for the approval of the medication by 
relevant stakeholders within the Ministry of Health. Further, this article refers to a clause in 
the previous article that states that the relevant committee within the Ministry of Health has 
the right to cancel licences for advertisements that fail to meet outlined criteria without the 
consideration of objections or the provision of compensation. While professionals in the 
communication industry are among the intended audience of the regulation, the law does 
not imply that they are intended audiences of the promotional materials.
Finally, the bylaws specify parties that may be held liable for violating the regulation 
by a criminal court. These parties are vaguely referred to as ‘all violators’ in Article 12, 
which potentially refers to individuals employed in the pharmaceutical industry, com-
munications industry, medical industry or administrative staff that may specialise in the 
registration of healthcare products. Noteworthy is the fact that Article 12 authorises the 
General Prosecutor’s Office to investigate and regulate all crimes related to the failure 
to adhere to these regulations. Such a clause clarifies that failure to adhere to these reg-
ulations would result in judiciary procedures handled by the criminal justice system, as 
opposed to the civil court system. Thus, there are high stakes involved in understanding 
the process of regulation. 
The GCC States
Medium Used
The GCC Health Ministers’ recommendations for the regulation of advertising pharma-
ceuticals make several references to the type of media used. Article 1 mandates that all 
materials used for the purposes of advertising and promotion must obtain prior approval 
and certification by the Health Ministers’ Council. These various materials used for adver-
tising and promotion are further explained in Article 2, which makes the most references 
to the types of media. 
In one of its clauses, Article 2 states that advertisements must provide consistent infor-
mation regarding the approved use of the medication, dosage, administration, warnings, 
side effects and possible drug interactions or dangerous circumstances pertaining to the 
consumption of the drug. In another clause, it places a price limit on educational media 
that can be provided to healthcare professionals and clarifies that these media can include 
books, as long as they are scientific. The article also limits other kinds of donations to hos-
pitals, gifts or in-kind contributions, by setting a price limit and stipulating that gifts are to 
be labelled with product names. However, no cash payments can be made to healthcare 
professionals in exchange for their encouragement to patients to take certain medications.
Article 2 also outlines other specifications for the content of advertising and promotional 
messages. For instance, the article requires all medical claims made in an advertisement to 
be supported by scientific evidence. This scientific study must be explained in an accurate 
and transparent way. The words ‘safe’ or ‘effective’ must only be used if published medical 
research supports such a claim. Comparisons of products, including generics, must be 
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both relevant to the product and presented in a medical format with statistics about their 
use. The original intent of information provided by a specialised medical source must not 
be distorted or misinterpreted in the content of advertising and promotional messages. 
Advertisers must not exaggerate characteristics of medications, and information about 
special ingredients in pharmaceuticals must be scientifically substantiated. Only moder-
ate usage of pharmaceutical products may be encouraged. 
There are particular conditions for which Article 2 also regulates the media content of 
advertising and promotional messages. In the case of a product recall, announcements 
are required to include contact information for the company marketing the pharmaceu-
tical products.
Article 4 further regulates the use of quotations in advertisements and promotional com-
munications. Quotes from scientific literature or personal communications must be 
verbatim. Adapting or modifying the quote is acceptable in some circumstances if three 
conditions are met. First, the quote must be labelled as adapted. Second, the source must 
be identified. Further, the original intention must not be changed. 
Article 5 regulates the use of the postal system for sending advertising and promotional 
purposes by giving health professionals the right to opt out of receiving advertisements 
and promotions. It also requires that the materials sent should be ‘reasonable’60 and must 
include precautionary information, with risks associated with pharmaceuticals as they are 
revealed. Article 9 requires sponsored scientific and/or educational activities delivered by 
a lecturer to be reported in printed materials distributed in meetings, naming brochures, 
advertisements and posters. 
Thus, the GCC regulations of pharmaceutical products and services are conceived of in 
a wide-ranging manner that does not limit the regulations to the mass media. In compar-
ison to the Kuwaiti regulation of advertising, GCC regulations encompass a wider scope 
and specifically mention various practices that are prohibited or conditionally allowed, 
for example, when regulating the use of quoted information. If similar regulations exist in 
Kuwait, their provisions were not located in Law 38 of 2002 or its bylaws.
Medication Advertised
The GCC regulations for promoting pharmaceuticals begin by emphasising the impor-
tance of adhering to the ethics of pharmacology and medicine. However, there are few 
references to the type of medications regulated by the codes. Although the first article 
explains that promoted medications must first be authorised for marketing via a licence, 
further details in the advertising and promotion guidelines do not specify which kinds 
of medications these regulations apply to. One notable exception lies in Article 6, which 
states that samples may not be provided if the pharmaceutical product contains a mind-al-
tering substance, such as a narcotic or psychotropic medication. The article then refers to 
laws on narcotic and psychotropic substances in the GCC states.
60  Khoja, Gulf Code, pp. 11–12.
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Intended Audience
Like the Kuwaiti regulations for the advertising of pharmaceuticals, the GCC regulations 
imply that there are multiple intended audiences for the advertisement and promotion of 
pharmaceuticals. The consumer is one such example of an intended audience. Article 3 
of the GCC regulations places the responsibility for educating patients, or potential con-
sumers of medications, on the pharmaceutical companies and healthcare professionals. 
Further, the third article adds conditions for this public education responsibility: truthful-
ness, accuracy, balance and conformity with other regulations. In addition to focusing on 
these ethical expectations to deliver information to the public, the third article expands 
the responsibility beyond just pharmaceutical products and services to public education 
relating to health conditions, such as particular diseases. 
Moreover, the GCC regulation targets multiple stakeholders. Several articles of the GCC 
regulations set a standard for advertising and promotion to members of pharmaceutical 
corporations, healthcare professionals, sales and advertising representatives, as well as 
others whose work may relate to the provision of medical or scientific expertise, including 
researchers, consultants and educators. 
Pharmaceutical corporations are subject to questioning from the public in addition to 
governing authorities, according to Article 2 of the GCC regulations. The article states that 
companies in the pharmaceutical industry are required to provide medical information 
that is referenced in promotional materials to anyone who asks for it, and the public is 
expected to ‘evaluate’61 this information. 
Healthcare professionals are also targeted by advertising and promotion regulation in 
several ways. For example, the provision of samples of pharmaceutical products to those 
qualified to prescribe medications is limited to certain ‘small quantities’62 and must be 
labelled as a free sample that is not to be sold. Further, an informational leaflet must 
accompany the sample. Healthcare professionals are able to opt out of advertising and 
promotional communications that are delivered by post, according to Article 5. This article 
also requires advertisers to send newsletters to update healthcare professionals on risks 
such as drug interactions, side effects or health conditions that may affect consumers.
Article 10 of the GCC regulations prevents sales and advertising representatives from 
disturbing healthcare professionals at pharmacies, hospitals or other types of healthcare 
facilities. Those selling and advertising pharmaceuticals, also referred to as third parties in 
Article 10, are required to understand scientific principles pertaining to the products they 
promote. All regulations pertaining to the pharmaceutical industry are applicable to those 
entrusted with advertising and sales. Training is required in order to ensure a ‘precise 
and complete’63 understanding of their clients’ products. Clause 11 of Article 2 states that 
any advertisements where competing products are mentioned must be limited to points 
related to the advertiser’s product. Clause 2 of Article 2 states that statistical information 
61  Ibid., p. 9.
62  Ibid., p. 12.
63  Ibid., pp. 14–15.
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from scientific studies comparing different drugs is required when a comparison is made 
to another product or a similar generic. In Clause 12 of Article 2, a 30-day time limit is set 
for advertisers to provide this information to produce comparative advertisements.
GCC regulations also contain requirements for other types of stakeholders, such as 
researchers, consultants and educators. Article 7 sets limits on hospitality offered to 
healthcare professionals to encourage their attendance at scientific meetings. Article 7 
sets standards for these expressions of hospitality, including requiring educational value, 
time dedicated to scientific endeavours and the application of local standards of modesty. 
Similarly, Article 8 allows healthcare professionals and consultants to be compensated 
for travel, lodging and meals conditionally. The conditions include a written contract that 
demonstrates that the expertise and services of the healthcare professional match those 
required for the consultation. Other healthcare professionals attending such consulta-
tions are required to be reported as well. Finally, Article 9 sets standards for the selection, 
payment and transparent communication of lecturers. While lecturers may be compen-
sated for travel, these payments must not be ‘exaggerated’64 and lecturers’ qualifications 
must be relevant to the information presented at the lecture. Further, any sponsorship 
of participants, either directly or indirectly, must be announced by the pharmaceutical 
company in printed materials distributed at lectures. Due to the inclusion of medical 
experts as stakeholders of the advertising regulation of pharmaceuticals, the GCC regula-
tions include more information about stakeholders than the Kuwaiti regulation. 
A final difference between Kuwaiti and GCC regulations deals with punitive measures for 
failure to comply. Article 11 of the GCC regulation requires that pharmaceutical corpora-
tions identify a representative who handles infringements of the regulations ‘in the Gulf 
country’.65 Each country can punish infringements of the regulation according to its own 
national laws and procedures. However, the GCC regulation encourages each company to 
provide corporate procedures for dealing with infringements. 
In Kuwait, the GCC regulations are considered recommendations. The General Pros-
ecutor’s Office is a specific judicial authority that is assigned authority to deal with 
infringements of regulations. Thus, two factors make the Kuwaiti regulation more appli-
cable to Kuwaiti society: its specificity and its legitimacy granted through the legislative 
process and the constitution.
64  Ibid., p. 14.
65  Ibid., p. 16.
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Conclusions and Implications
In examining Kuwaiti and GCC regulations on the advertising of pharmaceuticals with 
regard to the medium type, intended audience and type of medication, findings indicate 
that some cultural factors affect health communication and its regulation.
Kuwaiti and Gulf regulations are less tailored to specific media types than those of the UK, 
which regulate broadcast and print ads through different organisations, and the US, which 
set out different criteria for communicating risks and benefits of medications based on 
the medium employed. Kononova and Akbar’s finding that Kuwaiti oral tradition persists 
despite modernisation and a tendency to utilise communication technologies66 provides 
one possible explanation for this difference. Their findings, which the authors characterise 
as a feature of the Arab media landscape, demonstrate that interpersonal communica-
tion is a more effective way to exchange information than through the media, despite the 
latter’s perceived credibility. Similarly, interpersonal communications between govern-
mental officials and parties advertising pharmaceuticals may drive the way regulations 
apply to various media.
Noteworthy is the regulations’ emphasis on the adherence to certain ethical standards 
regardless of how the mediated message is disseminated. As Kuwaiti and GCC laws do 
not mention specific media and there are minimal references to the risks and benefits 
of medications, these laws are worded with fewer specifics. Such vaguely worded laws 
can be interpreted through cultural lenses that Lisa Wedeen67 describes as a tendency 
towards ambiguity due to an understanding that communication is often more symbolic 
than literal. Applying Wedeen’s perspective to the regulation of communication related to 
health promotion suggests that ambiguity can be subversive. For instance, a gap between 
performance of regulation and belief in the ethical protection of public health pushes 
participants in the health promotion system to uphold the system, while leaving health 
communication regulators ‘in the predicament of having to evaluate popular sentiment 
through the prism of enforced public dissimulation’.68 Although this tendency to com-
municate with ambiguity can lessen the belief in the ethical protection of public health 
through the regulation of health promotion advertisements, Arab communication pat-
terns can be described as indirect, which is typical of cultures that are collectivistic as 
opposed to individualistic.69 Individualistic cultures tend to engage in communication 
patterns that are verbal and directly show thoughts and feelings, whereas collectivistic 
cultures tend to rely on contextual social cues to interpret messages.70
66  Kononova and Akbar, ‘Interpersonal Communication’.
67  Lisa Wedeen, ‘Acting “As If”: Symbolic Politics and Social Control in Syria’, Comparative Studies in 
Society and History 40/3 (1998), pp. 503–23.
68  Ibid., p. 517.
69  Ellen Feghali, ‘Arab Cultural Communication Patterns’, International Journal of Intercultural Relations 
21/3 (1997), pp. 345–78.
70  Suraj Kapoor, Patrick C. Hughes, John R. Baldwin and Janet Blue, ‘The Relationship of Individualism–
Collectivism and Self-Construals to Communication Styles in India and the United States’, International 
Journal of Intercultural Relations 27/6 (2003), pp. 683–700.
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The cultural approach to communication does not preclude regulations of advertising 
from upholding values of truthfulness or transparency. This approach to communication 
sometimes manifests itself in the form of ambiguous wording, such as in references to 
values of truthfulness. For example, the GCC regulations call for accuracy and transpar-
ency, while the regulations by the US FDA specifically require communicating a balance 
between risks and benefits of the medication. This finding is consistent with the idea that 
universal values may appear in different forms, which Hafez71 demonstrated in an analysis 
of journalism ethics codes in several Muslim and non-Muslim nations.
The intended audiences of advertisements are secondary to other stakeholders affected 
by the Kuwaiti and GCC laws, indicating that health policies manage competition among 
pharmaceuticals more than they depend on consumer demands – two complementary 
policy approaches that do not need to be viewed in opposition.72 While the laws specifically 
recognise the role of advertisements in educating the public and protecting consumers, 
they emphasise that that the end-consumers of pharmaceutical products are likely to be 
influenced by healthcare professionals and those with relevant scientific expertise. This 
difference may be an effect of systematic differences, as the US is one of only two nations 
that allow pharmaceuticals to advertise prescription medications directly to consumers.73 
In nations where DTC advertising of prescription medications is prohibited by law, Shir-
Raz and Avraham74 found other public relations techniques utilised – including the use of 
press releases to members of medical associations or physicians, who would then deliver 
the message to consumers in a way that did not appear commercial. Approximately 75 
percent of Kuwait University students studying preclinical medicine and pharmacy report 
having been exposed to at least one promotional activity of a pharmaceutical corporation.75 
Kuwaiti students enrolled in pharmacy and medical colleges reported less training to deal 
with ethical issues surrounding the promotion of products by pharmaceutical corpora-
tions.76 Awad and Abahussain77 explain that Kuwaiti consumers may perceive pharmacists 
as a source of counsel for non-prescription medications.
Systematic differences in the healthcare sector may also reflect a cultural difference in the 
approach to power in different societies. Power distance is one factor that differentiates 
various cultures, and it is concerned with the distance at which individuals with power 
are treated.78 The attainment of education is one way social mobility occurs around the 
71  Kai Hafez, ‘Journalism Ethics Revisited: A Comparison of Ethics Codes in Europe, North Africa, the 
Middle East, and Muslim Asia’, Political Communication 19/2 (2002), pp. 225–50.
72  James C. Robinson, ‘Managed Consumerism in Health Care’, Health Affairs 24/6 (2005), pp. 1478–89.
73  Simon Gilbody, P. Wilson and I. Watt, ‘Benefits and Harms of Direct to Consumer Advertising: A Sys-
tematic Review’, Quality and Safety in Health Care 14/4 (2005), pp. 246–50.
74  Yaffa Shir-Raz and Eli Avraham, ‘“Under the Regulation Radar”: PR Strategies of Pharmaceutical Com-
panies in Countries Where Direct Advertising of Prescription Drugs Is Banned; The Israeli Case’, Public 
Relations Review 43/2 (2017), pp. 382–91.
75  Douglas E. Ball and Sara A. Al-Menea, ‘Exposure and Attitudes to Pharmaceutical Promotion Among 
Pharmacy and Medical Students in Kuwait’, Pharmacy Education 7 (2007), pp. 303–13, at p. 310.
76  Ibid., p. 309.
77  Abdelmoneim Awad and Eman Abahussain, ‘Health Promotion and Education Activities of Commu-
nity Pharmacists in Kuwait’, Pharmacy World & Science 32/2 (2010), pp. 146–53, at p. 150.
78  Gennadi Gevorgyan, ‘Does Culture Matter? Using Accommodation, Framing, and Hofstede Theories to 
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world and Kuwait is in general no exception.79 Thus, individuals equipped with an edu-
cation – including medical doctors and scientific researchers – may be more important 
stakeholders given the cultural context. This effect is amplified by the two-step flow of 
communication in Kuwait from educated opinion leaders to other members of society.80
Finally, the types of pharmaceutical products are labelled in the Kuwaiti and GCC regula-
tions differently from the ways in which they are analysed in the health communication 
literature. For example, Kuwaiti regulations distinguish between pharmaceuticals that may 
manage symptoms pertaining to veterinary, medical or herbal medicine. Along the same 
lines, GCC regulations make special provisions for mood-altering substances, such as nar-
cotics and psychotropic medications. Similar provisions exist in the British regulations. 
However, health communication scholars make the distinction between medications that 
would be administered in the short term and the long term.81 This temporal element relat-
ing to the use of pharmaceuticals is largely absent from the GCC and Kuwaiti regulations.
Provisions related to time are referenced when consumers request medical information in 
both the UK and GCC regulations. GCC regulations allow any person to request medical 
information, a provision made in the context of avoiding misleading communication about 
medication. In comparison, different lengths of time are provided for similar requests to 
examine the quality of medical information in British advertisements. For example, 30 
days are required for the MHRA to investigate a complaint. Vetting advertising materials 
can take up to several months and any materials submitted to the MHRA can take up to 5 
business days. When a complaint is written about a specific advertisement, 4–6 weeks are 
set aside for an oral hearing.
In other words, the theme of specificity once again emerges in relation to time, which 
is consistent with Douai’s findings82 that time is perceived with more fluidity than in 
Western societies. He suggests that time is managed differently and the advertising reg-
ulation reflects this due to the differences in the specificity regarding different types of 
deadlines for dealing with complaints.83
The differences in the cultural perceptions of time were reflected in the vaguer phrasing 
of the Arabic-language regulations analysed compared to the Western regulations. Never-
theless, risks of medications for long-term conditions were less likely to be reported on 
the websites of pharmaceutical companies in the US than those of short-term conditions.84 
Thus, time as a culturally specific construct is factored in when developing communica-
tions strategies for pharmaceutical products.
Predict Chinese Voters’ Perceptions and Attitudes Toward Culturally Oriented Online Political Advertis-
ing’, China Media Research 6/1 (2010), pp. 91–103.
79  Shafeeq Ghabra, ‘Kuwait and the Dynamics of Socio-Economic Change’, The Middle East Journal 51/3 
(1997), pp. 358–72.
80  Kononova and Akbar, ‘Interpersonal Communication’.
81  Huh and Cude, ‘Is the Information “Fair and Balanced”?’.
82  Aziz Douai, ‘Media Research in the Arab World and the Audience Challenge: Lessons from the Field’, 
Journal of Arab & Muslim Media Research 3/1–2 (2010), pp. 77–88.
83  Ibid.
84  Huh and Cude, ‘Is the Information “Fair and Balanced”?’.
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It is important to account for cultural differences when examining regulations of medici-
nal advertisements because regulations need to be enforced by actors that follow certain 
cultural norms. Behbehani85 cites religious and fatalistic attitudes used as justification 
among older Kuwaiti women as a reason to neglect one’s health. This is not unique to 
Kuwait, as Ypinazar and Margolis86 found it to be true in other Arab Gulf states as well. 
Several adjustments can be made to improve the current advertising regulation of phar-
maceutical products in Kuwait and the Gulf. Firstly, health literacy87 can be promoted 
to improve communication practices that allow individuals to learn how to interpret 
health-related information with more accuracy and efficiency. Nutbeam defines health 
literacy as a combination of health-related education and communication that enables 
individuals to make decisions that give them more control over the circumstances of their 
health.88 He goes on to demonstrate the usefulness of the concept, observing that even the 
same medications can be less effective when they are not administered properly. 
Secondly, the development of health communication programmes can help with improving 
health literacy among Kuwaitis and citizens of the GCC. While many academic communi-
cation programmes are emerging around the Gulf, few, if any, offer health communication 
certificates or degrees. In an effort to promote health literacy in Kuwait, a public relations 
campaign focusing on food safety utilised an innovative communication strategy, pro-
viding translations into five commonly-used languages: Arabic, English, Hindi, Malayam 
and Tagalog.89 Similar efforts should be examined for effectiveness and studied in other 
health-related communication contexts. 
Finally, health communication researchers cite issues with data privacy and the protection 
of consumers of pharmaceuticals around the world. Few provisions in the Kuwaiti and 
GCC regulations address data privacy issues, which may occur when search engines are 
used to learn more about medications and illnesses. The fact that many search engines are 
run by multinational corporations also raises the issue of how to regulate health-related 
information coming from points of origin outside of the receiving country’s jurisdiction. 
This study’s contributions are in its examination of media regulations of health-related 
products in Kuwait and the comparison with norms in the GCC. Although the three regu-
latory documents were analysed in some depth, the study’s conclusions are restricted by 
the number of regulations investigated. Further, this study examines regulatory standards, 
not the actual practice of the regulation of pharmaceutical advertisements. Future studies 
could examine regulations in the remaining Gulf states, and also the effects of pharma-
ceutical advertisements on populations in Kuwait and the Gulf. 
85  Behbehani, ‘Kuwait National Programme for Healthy Living’.
86  Valmae Anne Ypinazar and Stephen Andrew Margolis, ‘Delivering Culturally Sensitive Care: The Per-
ceptions of Older Arabian Gulf Arabs Concerning Religion, Health, and Disease’, Qualitative Health 
Research 16/6 (2006), pp. 773–87.
87  Don Nutbeam, ‘The Evolving Concept of Health Literacy’, Social Science & Medicine 67/12 (2008), pp. 
2072–8.
88  Ibid.
89  Mariam F. Alkazemi, Fahed Al-Sumait and Cristina Navarro, ‘Communicating Food Safety in the 
Highly Multicultural Country of Kuwait’, in Judy VanSlyke Turk and Jean Valin (eds), Public Relations 
Case Studies from Around the World, 2nd edition (New York: Peter Lang, 2017).
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